Guide for Authors
The
European Journal of Pharmaceutics and Biopharmaceutics provides a medium for publication
of novel and innovative research from areas of pharmaceutical technology, drug delivery systems, controlled release systems, drug targeting,
physical pharmacy, biopharmaceutics, drug development, drug and prodrug design, pharmaceutical analysis, drug stability, quality control,
GMP, regulatory aspects, pharmaceutical packaging, and phytochemistry.
The pharmaceutical biotechnology section provides a forum
for the publication of papers on scientific, developmental, regulatory and manufacturing issues concerning the development of biopharmaceuticals,
uniquely combining expert contributions and opinions of authors from the fields of pharmaceutics and biotechnology. This scope encompasses
modern biopharmaceuticals (e.g., proteins and nucleic acids), biosimilars/biogenerics as well as 'traditional' products such as antibiotics.
"THE RULES OF 3"
The Editors and Editorial board have developed the "Rules of 3". Authors must consider the following
three criteria before they submit a manuscript and set the whole process of editing and reviewing at work. The rules are also used as
guidelines for the peer review of manuscripts.
CLICK
HERE to view the "Rules of 3".
Authors are encouraged to submit video material or animation sequences
to support and enhance your scientific research. For more information please see the paragraph on video data below.
Types of paper
The following types of papers are considered by the Editors: Research Papers, Review Articles,
Short Reviews, and Notes.
Ethics in publishing
For
information on Ethics in publishing and Ethical guidelines for journal publication see
http://www.elsevier.com/publishingethics
and
http://www.elsevier.com/ethicalguidelines.
Policy and ethics
The work
described in your article must have been carried out in accordance with
The Code of Ethics of the World Medical Association (Declaration
of Helsinki) for experiments involving humans 
http://www.wma.net/en/30publications/10policies/b3/index.html;
EU
Directive 2010/63/EU for animal experiments http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm;
Uniform Requirements for manuscripts submitted to Biomedical journals http://www.icmje.org. This must be stated
at an appropriate point in the article.
Conflict of interest
All authors are requested to
disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations
within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. See
also
http://www.elsevier.com/conflictsofinterest.
Submission declaration
Submission
of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published
lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors
and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published
elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder.
Changes to authorship
This policy concerns the addition, deletion, or rearrangement of author names in the
authorship of accepted manuscripts:
Before the accepted manuscript is published in an online issue: Requests to add or remove
an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript
and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail,
fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors,
this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded
by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers
will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until
authorship has been agreed.
After the accepted manuscript is published in an online issue: Any requests to add, delete, or
rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement'
(for more information on this and copyright see
http://www.elsevier.com/copyright). Acceptance of the agreement will ensure
the widest possible dissemination of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript
together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce
tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of
the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations
and translations (please consult
http://www.elsevier.com/permissions). If excerpts from other copyrighted works are included,
the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted
forms for use by authors in these cases: please consult
http://www.elsevier.com/permissions.
Retained
author rights
As an author you (or your employer or institution) retain certain rights; for details you are referred to:
http://www.elsevier.com/authorsrights.
Role of the funding source
You are requested
to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe
the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report;
and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Please see
http://www.elsevier.com/funding.
Funding body agreements and policies
Elsevier
has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply
with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements
and policies please visit
http://www.elsevier.com/fundingbodies.
Open access
This
journal offers you the option of making your article freely available to all via the ScienceDirect platform. To prevent any conflict
of interest, you can only make this choice after receiving notification that your article has been accepted for publication. The fee
of $3,000 excludes taxes and other potential author fees such as color charges. In some cases, institutions and funding bodies have entered
into agreement with Elsevier to meet these fees on behalf of their authors. Details of these agreements are available at
http://www.elsevier.com/fundingbodies.
Authors of accepted articles, who wish to take advantage of this option, should complete and submit the order form (available at
http://www.elsevier.com/locate/openaccessform.pdf).
Whatever access option you choose, you retain many rights as an author, including the right to post a revised personal version of your
article on your own website. More information can be found here:
http://www.elsevier.com/authorsrights.
Language and language services
Please write your text in good English (American or British usage is accepted,
but not a mixture of these). Authors who require information about language editing and copyediting services pre- and post-submission
please visit
http://webshop.elsevier.com/languageservices
or our customer support site at
http://support.elsevier.com
for more information.
Submission
Submission to this journal proceeds totally online and
you will be guided stepwise through the creation and uploading of your files. The system automatically converts source files to a single
PDF file of the article, which is used in the peer-review process. Please note that even though manuscript source files are converted
to PDF files at submission for the review process, these source files are needed for further processing after acceptance. All correspondence,
including notification of the Editor's decision and requests for revision, takes place by e-mail removing the need for a paper trail.
Referees
You are requested to name at least 5 international experts as possible reviewers for your manuscript,
providing their names, affiliations and email addresses.
Please note that the reviewers you suggest should:
- not be from
the same country as you
- not have been collaborators of yours in the past 2 years
- not be members of the Editorial
Board of the journal
Additional information
US National Institutes of Health
(NIH) voluntary posting ("Public Access") policy.
Elsevier facilitates author posting in connection with the voluntary posting
request of the NIH (referred to as the NIH "Public Access Policy"; see
http://publicaccess.nih.gov/) by posting the peer-reviewed
author's manuscript directly to PubMed Central on request from the author, after formal publication. Upon notification from Elsevier
of acceptance, we will ask you to confirm via e-mail (by e-mailing us at
NIHauthorrequest@elsevier.com) that your work
has received NIH funding (with the NIH award number, as well as the name and e-mail address of the Prime Investigator) and that you intend
to respond to the NIH request. Upon such confirmation, Elsevier will submit to PubMed Central on your behalf a version of your manuscript
that will include peer-review comments, for posting 12 months after the formal publication date. This will ensure that you will have
responded fully to the NIH request policy. There will be no need for you to post your manuscript directly with PubMed Central, and any
such posting is prohibited. Individual modifications to this general policy may apply to some Elsevier journals and its society publishing
partners.
Use of wordprocessing software
It
is important that the file be saved in the native format of the wordprocessor used. The text should be in single-column format. Keep
the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular,
do not use the wordprocessor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts
etc. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If
no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional
manuscripts (see also the Guide to Publishing with Elsevier:
http://www.elsevier.com/guidepublication). Note that source
files of figures, tables and text graphics will be required whether or not you embed your figures in the text. See also the section on
Electronic artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of
your wordprocessor.
LaTeX
If the LaTeX file is suitable, proofs will be produced without
rekeying the text. The article should preferably be written using Elsevier's document class 'elsarticle', or alternatively any of the
other recognized classes and formats supported in Elsevier's electronic submissions system, for further information see
http://www.elsevier.com/wps/find/authorsview.authors/latex-ees-supported.
The Elsevier 'elsarticle' LaTeX style file package (including detailed instructions for LaTeX preparation) can be obtained
from the Quickguide:
http://www.elsevier.com/latex. It consists of the file: elsarticle.cls, complete user documentation
for the class file, bibliographic style files in various styles, and template files for a quick start.
RESEARCH
PAPERS
Should contain the following sections: Introduction, Theoretical Development (if applicable), Materials and Methods,
Results, Discussion (or Results and Discussion) and References. For purely theoretical papers, appropriate sections may be selected.
It should define the purpose of the research and reveal its connections with the principal work of other authors in the
field.
Materials and methods
It should include materials, standard techniques and procedures
relevant to the study. Published procedures and techniques should be cited unless significant modifications are involved. Exact specification
of relevant materials and equipment must be given. Chemical terms must conform with IUPAC rules. Trademarks of commercial products must
be labelled using a superscripted '(r)'. Names of products and equipment mentioned in the Materials and Methods section must be accompanied
by the name of the manufacturer or distributor, location and state or country. This information must be stated in parentheses in the
text, and not as a footnote. Any potential hazards connected with materials and procedures must be mentioned. A precise and detailed
description should be given of those steps which are of vital importance in carrying out any repetition of the work. The Declarations
of Helsinki and Tokyo for humans, and the European Community guidelines as accepted principles for the use of experimental animals, must
be adhered to. Therefore,
EJPB will only consider manuscripts that describe experiments that have been carried out under approval
of an institutional or local ethics committee.
Authors must state in the manuscript that the protocol complies with the particular
recommendation and that approval of their protocols was obtained.
Equations must be part of the text and consecutively
numbered on the right hand side using numbers in parentheses. References to equations in the text are also to be made with parentheses,
e.g. using Eq. (3), etc.
Organic formulas, both in figures and in the text, should be numbered in boldface arabic numerals.
SI units must be used throughout.
Theory/calculation
A Theory section should
extend, not repeat, the background to the article already dealt with in the Introduction and lay the foundation for further work. In
contrast, a Calculation section represents a practical development from a theoretical basis.
Results
Results
may be presented in tables, figures or schemes which must be referred to in the accompanying text, using appropriate numbering, e.g.
Fig. 1, Table 2.
Discussion
It should focus on the interpretation of the results. It might
be appropriate to combine RESULTS AND DISCUSSION in one section. If necessary at all, use CONCLUSIONS only to illustrate the general
implication of the results and do not summarize the previous text.
Conclusions
The main
conclusions of the study may be presented in a short Conclusions section, which may stand alone or form a subsection of a Discussion
or Results and Discussion section.
Appendices
If there is more than one appendix, they should
be identified as A, B, etc. Formulae and equations in appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a
subsequent appendix, Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc.
Essential
title page information
•
Title.
Concise and informative. Titles are often used in information-retrieval
systems. Avoid abbreviations and formulae where possible.
•
Author names and affiliations.
Where the family name
may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work
was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in
front of the appropriate address. Provide the full postal address of each affiliation, including the country name and, if available,
the e-mail address of each author.
•
Corresponding author.
Clearly indicate who will handle correspondence at
all stages of refereeing and publication, also post-publication.
Ensure that telephone and fax numbers (with country and area code)
are provided in addition to the e-mail address and the complete postal address. Contact details must be kept up to date by the corresponding
author.
•
Present/permanent address.
If an author has moved since the work described in the article was done,
or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address
at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for
such footnotes.
It should contain a brief and clear description of the aim of the paper, its principal
results and major conclusions (100--200 words). The abstract should include all keywords pertinent to the subject.
Graphical abstract
A Graphical abstract is mandatory for this journal. It should summarize the contents of
the article in a concise, pictorial form designed to capture the attention of a wide readership online. Authors must provide images that
clearly represent the work described in the article. Graphical abstracts should be submitted as a separate file in the online submission
system. Image size: please provide an image with a minimum of 531 × 1328 pixels (h × w) or proportionally more. The image
should be readable at a size of 5 × 13 cm using a regular screen resolution of 96 dpi. Preferred file types: TIFF, EPS, PDF or
MS Office files. See
http://www.elsevier.com/graphicalabstracts for examples.
Authors can make use of Elsevier's Illustration
and Enhancement service to ensure the best presentation of their images also in accordance with all technical requirements:
Illustration Service.
Keywords
Indicate 5 to
10 English keywords. They should be carefully selected in order to improve accessibility of scientific information in the manuscript.
Keywords commonly used in international abstracting services will be preferred.
Abbreviations
Define
abbreviations that are not standard in this field in a footnote to be placed on the first page of the article. Such abbreviations that
are unavoidable in the abstract must be defined at their first mention there, as well as in the footnote. Ensure consistency of abbreviations
throughout the article.
Acknowledgements
Acknowledgements of financial support, gifts,
technical help or other assistance may be given in an unnumbered paragraph under this heading preceding the references.
Database linking
Elsevier aims at connecting online articles with external databases which are useful in their
respective research communities. If your article contains relevant unique identifiers or accession numbers (bioinformatics) linking to
information on entities (genes, proteins, diseases, etc.) or structures deposited in public databases, then please indicate those entities
according to the standard explained below.
Authors should explicitly mention the
database abbreviation (as mentioned below) together
with the actual database number, bearing in mind that an error in a letter or number can result in a dead link in the online version
of the article.
Please use the following format:
Database ID: xxxx
Links can be provided in your online article to the following
databases (examples of citations are given in parentheses):
•
ASTM: ASTM
Standards Database (ASTM ID: G63)
•
CCDC: Cambridge Crystallographic
Data Centre (CCDC ID: AI631510)
•
GenBank: Genetic sequence
database at the National Center for Biotechnology Information (NCBI) (GenBank ID: BA123456)
•
GEO:
Gene Expression Omnibus (GEO ID: GSE27196; GEO ID: GPL5366; GEO ID: GSM9853)
•
MI:
EMBL-EBI OLS Molecular Interaction Ontology (MI ID: 0218)
•
MINT:
Molecular INTeractions database (MINT ID: 6166710)
•
NCBI Taxonomy:
NCBI Taxonomy Browser (NCBI Taxonomy ID: 48184)
•
NCT: ClinicalTrials.gov
(NCT ID: NCT00222573)
•
OMIM: Online Mendelian Inheritance
in Man (OMIM ID: 601240)
•
PDB: Worldwide Protein Data
Bank (PDB ID: 1TUP)
•
TAIR: The Arabidopsis Information Resource
database (TAIR ID: AT1G01020)
•
UniProt: Universal Protein Resource
Knowledgebase (UniProt ID: Q9H0H5)
Math formulae
Present simple formulae in the line of
normal text where possible and use the solidus (/) instead of a horizontal line for small fractional terms, e.g., X/Y. In principle,
variables are to be presented in italics. Powers of e are often more conveniently denoted by exp. Number consecutively any equations
that have to be displayed separately from the text (if referred to explicitly in the text).
Footnotes
Footnotes
should be used sparingly. Number them consecutively throughout the article, using superscript Arabic numbers. Many wordprocessors build
footnotes into the text, and this feature may be used. Should this not be the case, indicate the position of footnotes in the text and
present the footnotes themselves separately at the end of the article. Do not include footnotes in the Reference list.
Table
footnotes
Indicate each footnote in a table with a superscript lowercase letter.
Artwork
Electronic artwork
General points
• Make sure you use uniform lettering and sizing of your
original artwork.
• Save text in illustrations as 'graphics' or enclose the font.
• Only use the following fonts in
your illustrations: Arial, Courier, Times, Symbol.
• Number the illustrations according to their sequence in the text.
•
Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Produce images
near to the desired size of the printed version.
• Submit each figure as a separate file.
A detailed guide on electronic
artwork is available on our website:
http://www.elsevier.com/artworkinstructions
You are urged to visit this
site; some excerpts from the detailed information are given here.
Formats
Regardless of the application used, when
your electronic artwork is finalised, please 'save as' or convert the images to one of the following formats (note the resolution requirements
for line drawings, halftones, and line/halftone combinations given below):
EPS: Vector drawings. Embed the font or save the text
as 'graphics'.
TIFF: Color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings:
use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.
If
your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 'as is'.
Please
do not:
• Supply files that are optimised for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too low;
•
Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Figures
Figures must be presented on separate sheets in consecutive order using Arabic numerals. Each figure
should be provided with an instructive title and explanatory information. The legend should be typed separately from the figures. To
ensure identification of the figures, indicate figure number and name of author using soft pencil. Submit original drawings in black
ink on good quality white paper. High-contrast photographs are equally acceptable. One original set is required with the submission.
Numbering and lettering of figures should be carefully accepted in order to ensure readability after photographic reduction of the figure.
Use only standard symbols to mark datapoints. Explanation of curves and symbols should be in the legend rather than part of the drawing,
unless this is detrimental to clarity. Indicate SI units of measure in parentheses.
Colour illustrations should be submitted
as original photographs, high-quality computer prints or transparancies, close to the size expected in publication or as 35 mm slides.
Polaroid colour prints are
not suitable. If, together with your accepted article, you submit usable colour figures then Elsevier
will ensure , at no additional charge, that these figures will appear in colour on the web (e.g., ScienceDirect and other sites) regardless
of whether or not these illustrations are reproduced in colour in the printed version. For colour reproduction in print, you will receive
information regarding the total cost from Elsevier after receipt of your accepted article. For more detailed instructions please visit
our artwork instruction pages at
http://www.elsevier.com/artworkinstructions.
Please note: Because of
technical complications which can arise by converting colour figures to 'grey scale' (for the printed version should you not opt for
colour in print) please submit in addition usable black and white prints corresponding to all the colour illustrations.
A limited
number of colour photographs are accepted free of charge with prior permission from the Editor-in-Chief. Colour photographs above this
number will only be reproduced at the expense of the author(s). The 2006 price for colour figures is 285 Euro for the first page and
191 Euro for subsequent pages.
Figure captions
Ensure that each illustration has a caption.
Supply captions separately, not attached to the figure. A caption should comprise a brief title (
not on the figure itself) and
a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Tables
Tables must be presented on separate sheets in consecutive order using Arabic numerals. The table headings
must include a descriptive title and additional information to make the table self-explanatory. Some information may be given by using
lower-case letter designations referring to footnotes at the bottom of the table. Indicate SI units of measure in parentheses.
References
References must be arranged as follows:
[1] A.– L. Cornaz, P. Buri, Nasal mucosa as
an absorption barrier, Eur. J. Pharm. Biopharm. 40 (1994) 261– 270.
[5] C. Lanczos, Applied Analysis, Prentice-Hall, Englewood
Cliffs, NJ, 1967, pp. 272– 280.
[10] D.M. Barends, Stability of active ingredients, in: H. Mü ller, W.H. Oeser (Eds.),
Drug Master Files, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, Germany, 1992, pp. 121– 128.
[14] E.A. Balazs,
Ultrapure hyaluronic acid and the use thereof, U.S. Patent 4,141,973 (1979).
The system used by Chemical Abstracts (Chemical Abstracts
Service Source Index) must be followed for the abbreviations of journals. Reference (4) is for patents, including the status, international
country code, number of patent and year.
Articles in Special Issues: Please ensure that the words 'this issue' are added (in
the list and text) to any references to other articles in this Special Issue.
Citation in text
Please
ensure that every reference cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract
must be given in full. Unpublished results and personal communications are not recommended in the reference list, but may be mentioned
in the text. If these references are included in the reference list they should follow the standard reference style of the journal and
should include a substitution of the publication date with either 'Unpublished results' or 'Personal communication'. Citation of a reference
as 'in press' implies that the item has been accepted for publication.
Web references
As
a minimum, the full URL should be given and the date when the reference was last accessed. Any further information, if known (DOI, author
names, dates, reference to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the
reference list) under a different heading if desired, or can be included in the reference list.
References
in a special issue
Please ensure that the words 'this issue' are added to any references in the list (and any citations
in the text) to other articles in the same Special Issue.
Reference management software
This
journal has standard templates available in key reference management packages EndNote (
http://www.endnote.com/support/enstyles.asp)
and Reference Manager (
http://refman.com/support/rmstyles.asp). Using plug-ins to wordprocessing packages, authors only
need to select the appropriate journal template when preparing their article and the list of references and citations to these will be
formatted according to the journal style which is described below.
Reference style
Text:
Indicate references by number(s) in square brackets in line with the text. The actual authors can be referred to, but the reference number(s)
must always be given.
Example: '..... as demonstrated [3,6]. Barnaby and Jones [8] obtained a different result ....'
List:
Number the references (numbers in square brackets) in the list in the order in which they appear in the text.
Examples:
Reference to a journal publication:
[1] J. van der Geer, J.A.J. Hanraads, R.A. Lupton, The art of writing a scientific article,
J. Sci. Commun. 163 (2010) 51–59.
Reference to a book:
[2] W. Strunk Jr., E.B. White, The Elements of Style, fourth ed.,
Longman, New York, 2000.
Reference to a chapter in an edited book:
[3] G.R. Mettam, L.B. Adams, How to prepare an electronic
version of your article, in: B.S. Jones, R.Z. Smith (Eds.), Introduction to the Electronic Age, E-Publishing Inc., New York, 2009, pp.
281–304.
Journal abbreviations source
Journal names should be abbreviated according
to
Index Medicus journal abbreviations:
http://www.nlm.nih.gov/tsd/serials/lji.html;
List of title word abbreviations:
http://www.issn.org/2-22661-LTWA-online.php;
CAS (Chemical Abstracts Service):
http://www.cas.org/sent.html.
Video data
Elsevier accepts video material and animation sequences to support and enhance your scientific
research. Authors who have video or animation files that they wish to submit with their article are strongly encouraged to include these
within the body of the article. This can be done in the same way as a figure or table by referring to the video or animation content
and noting in the body text where it should be placed. All submitted files should be properly labeled so that they directly relate to
the video file's content. In order to ensure that your video or animation material is directly usable, please provide the files in one
of our recommended file formats with a preferred maximum size of 50 MB. Video and animation files supplied will be published online in
the electronic version of your article in Elsevier Web products, including ScienceDirect:
http://www.sciencedirect.com.
Please supply 'stills' with your files: you can choose any frame from the video or animation or make a separate image. These will be
used instead of standard icons and will personalize the link to your video data. For more detailed instructions please visit our video
instruction pages at
http://www.elsevier.com/artworkinstructions. Note: since video and animation cannot be embedded in
the print version of the journal, please provide text for both the electronic and the print version for the portions of the article that
refer to this content.
Supplementary data
Elsevier accepts electronic supplementary material
to support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting
applications, high-resolution images, background datasets, sound clips and more. Supplementary files supplied will be published online
alongside the electronic version of your article in Elsevier Web products, including ScienceDirect:
http://www.sciencedirect.com.
In order to ensure that your submitted material is directly usable, please provide the data in one of our recommended file formats. Authors
should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file.
For more detailed instructions please visit our artwork instruction pages at
http://www.elsevier.com/artworkinstructions.
Submission checklist
The following list will be useful during the final checking of an article prior to sending
it to the journal for review. Please consult this Guide for Authors for further details of any item.
Ensure that the following
items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
• Telephone and fax numbers
All necessary files have been uploaded, and contain:
•
Keywords
• All figure captions
• All tables (including title, description, footnotes)
Further considerations
•
Manuscript has been 'spell-checked' and 'grammar-checked'
• References are in the correct format for this journal
•
All references mentioned in the Reference list are cited in the text, and vice versa
• Permission has been obtained for use
of copyrighted material from other sources (including the Web)
• Color figures are clearly marked as being intended for color
reproduction on the Web (free of charge) and in print, or to be reproduced in color on the Web (free of charge) and in black-and-white
in print
• If only color on the Web is required, black-and-white versions of the figures are also supplied for printing purposes
For any further information please visit our customer support site at
http://support.elsevier.com.
Use of the Digital
Object Identifier
The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists
of a unique alpha-numeric character string which is assigned to a document by the publisher upon the initial electronic publication.
The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly 'Articles in press' because they
have not yet received their full bibliographic information. The correct format for citing a DOI is shown as follows (example taken from
a document in the journal
Physics Letters B):
doi:10.1016/j.physletb.2010.09.059
When you use the DOI to create URL
hyperlinks to documents on the web, the DOIs are guaranteed never to change.
Proofs
One
set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do not have an e-mail address then paper
proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download the files themselves. Elsevier now
provides authors with PDF proofs which can be annotated; for this you will need to download Adobe Reader version 7 (or higher) available
free from
http://get.adobe.com/reader. Instructions on how to annotate PDF files will accompany the proofs (also given online).
The exact system requirements are given at the Adobe site:
http://www.adobe.com/products/reader/tech-specs.html.
If
you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return them
to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark the corrections
and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail,
or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures.
Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor.
We will do everything possible to get your article published quickly and accurately – please let us have all your corrections within
48 hours. It is important to ensure that all corrections are sent back to us in one communication: please check carefully before replying,
as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed
with the publication of your article if no response is received.
Offprints
The corresponding
author, at no cost, will be provided with a PDF file of the article via e– mail. The PDF file is a watermarked version of the published
article and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use.
Additional information
No responsibility is assumed by the Publisher for any injury and/or damage to persons
or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions
or ideas contained in the material herein. Because of the rapid advances made in the medical sciences, independent verification of diagnoses
and drug dosages should be made.
Review of manuscripts
Upon receipt, a manuscript will be peer-reviewed. The
reviewers' relevant comments and the editor's decision will be communicated to the authors.
TITLE
It should
be carefully chosen to provide precise information about the contents and include important keywords. The title should be followed by
the full name(s) of the author(s) and by his (her, their) affiliation(s). Different affiliations should be indicated by suitable superscripts.
To ensure identification of the corresponding author, please indicate full name, full postal address, e-mail address, phone and facsimile
on the cover of the manuscript.
RESEARCH PAPERS
Should contain the following sections: Introduction, Theoretical
Development (if applicable), Materials and Methods, Results, Discussion (or Results and Discussion) and References. For purely theoretical
papers, appropriate sections may be selected.
USE OF DIGITAL OBJECT IDENTIFIER (DOI)
The digital object identifier
(DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned
to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium
for citing a document particularly "Articles in press" because they have not yet received their full bibliographic information.
The correct format for citing DOI is shown as follows: doi:10.1016/j.ejpb.2004.10.006
Notes
The research
and technical notes section of the journal (maximum 2500 words) is open to interesting results worthy of publication without requiring
extensive introduction and discussion. This section should contain the following subheadings: Abstract, Introduction, Materials and Methods,
Results and Discussion (combined). No more than 10 references should be used. Tables, figures and references are to be arranged according
to research papers. Brevity of presentation is essential for this section. Five to 10 keywords should be provided.
Review
articles
The organization and subdivision of review articles can be arranged at the author's discretion. Tables, figures
and references are to be arranged according to research papers. An abstract, table of contents, and keywords are requested.
Correcting
proofs and reprints
Elsevier will send PDF proofs to authors by e-mail for correction. If an author is unable to handle
this process, regular print proofs will be sent. Elsevier will do everything possible to get the article corrected and published as quickly
and accurately as possible. Therefore, it is important to ensure that all corrections are sent back in one communication. Subsequent
corrections will not be possible. Only typesetting errors may be corrected; no changes in, or additions to, the accepted manuscript will
be allowed. Proofs should be returned to Elsevier within 48 hours.
EJPB has no page charges. Fifty offprints of each
paper will be supplied free of charge to the corresponding author. Additional offprints can be ordered at prices shown on the offprint
order form that accompanies the copyright form.
For inquiries relating
to the submission of articles (including electronic submission) please visit this journal's homepage. Contact details for questions arising
after acceptance of an article, especially those relating to proofs, will be provided by the publisher. You can track accepted articles
at
http://www.elsevier.com/trackarticle. You can also check our Author FAQs (
http://www.elsevier.com/authorFAQ)
and/or contact Customer Support via
http://support.elsevier.com.
